Optimization of anti-ADAMTS13 antibodies for the treatment of ADAMTS13-related bleeding disorder in patients receiving circulatory assist device support
Abstract ADAMTS13 (a disintegrin-like and metalloproteinase with thrombospondin type-1 motif 13)-related bleeding disorder has been frequently observed as a life-threatening clinical complication in patients carrying a circulatory assist device. Currently, treatment modalities for the bleeding disor...
Guardado en:
Autores principales: | Toshihiro Ito, Takeharu Minamitani, Masaki Hayakawa, Ryota Otsubo, Hiroki Akiba, Kouhei Tsumoto, Masanori Matsumoto, Teruhito Yasui |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/56ea2f8987bd4ff3a9909e359a9b94c8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Crystal structure and substrate-induced activation of ADAMTS13
por: Anastasis Petri, et al.
Publicado: (2019) -
Expression of ADAMTS13 and PCNA in the Placentas of Gestational Diabetic Mothers
por: Oglak,Süleyman Cemil, et al.
Publicado: (2021) -
Novel neutralizing human monoclonal antibodies against tetanus neurotoxin
por: Takeharu Minamitani, et al.
Publicado: (2021) -
DEFICIENCY OF ADAMTS-13 IN SEPSIS PATIENTS AND ITS CORRELATION WITH MORBIDITY/ MORTALITY
por: Syed Owais Ali, et al.
Publicado: (2021) -
Role of ADAMTS13, VWF and F8 genes in deep vein thrombosis.
por: Maria Teresa Pagliari, et al.
Publicado: (2021)